Development Pipeline
Since its founding, Interleukin Genetics has dedicated itself to discovering genetic variation research and defining products that empower personal health choices.
Interleukin's product development is focused on the fact that certain genetic variations among individuals produce life-long differences in their body’s responses to disease and drugs. Interleukin's proprietary genetic technology helps to identify individuals who have a life-long tendency to over or under-express key chemicals in the body that lead to more disease as they age. Individuals with these genetic differences also respond differently to certain treatments or drugs.
| Key milestones completed | |
|---|---|
Osteoporosis genetic test - North America | Two clinical/biomarker association studies completed |
General nutrition genetic test - International | Clinical/biomarker association study completed |
IL1 Cardiovascular genetic test - International | Clinical/biomarker association study completed |
Weight management genetic test -North America | Clinical/biomarker association study in progress |
PerioNx - North America | Lead candidates identified |
Skin Aging genetic test - North America | Clinical/biomarker association study designed |
Osteoporosis genetic test - International | Clinical/biomarker association study in design phase |